Treatment of melanoma

Details for Australian Patent Application No. 2008226582 (hide)

Owner Novartis AG

Inventors Heise, Carla C.; Rendahl, Katherine; Menezes, Daniel; Pryer, Nancy; Hollenbach, Paul; Wiesmann, Marion

Agent Davies Collison Cave

Pub. Number AU-B-2008226582

PCT Pub. Number WO2008/112509

Priority 60/911,406 12.04.07 US; 60/894,046 09.03.07 US

Filing date 7 March 2008

Wipo publication date 18 September 2008

Acceptance publication date 21 July 2011

International Classifications

A61K 31/4375 (2006.01)

A61K 31/4709 (2006.01) - Non-condensed quinolines containing further heterocyclic rings

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61P 35/04 (2006.01) Antineoplastic agents

Event Publications

10 September 2009 PCT application entered the National Phase

  PCT publication WO2008/112509 Priority application(s): WO2008/112509

21 July 2011 Application Accepted

  Published as AU-B-2008226582

17 November 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008226584-Reconfigurable mobile mode and fixed network mode endpoint meters

2008226570-Method and system for pairing of wireless devices using physical presence